25/08/2016 23:19:20 1-888-992-3836 (toll free) Free Membership Login

Mylan N.V. News (NASDAQ:MYL)

DateTimeSource
Headline
08/25/20169:45AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Thursday's session are Medtronic PLC (MDT), Signet Jewelers Ltd. (SIG) and Sears Holdings Corp. (SHLD). Medtronic PLC said sales fell in the latest period across most of its segments, though the medical device maker's profit grew thanks to lower expenses... More...>>
08/25/20168:30AMDJNMylan Boosts Price Assistance for EpiPen Amid Backlash
Mylan NV responded Thursday to backlash over price increases for its EpiPen emergency allergy treatment by promising to reduce the costs that some patients pay, though the drugmaker stopped short of saying it would roll back prices or limit future increases. EpiPen is a lifesaving treatment for millions whose allergies... More...>>
08/25/20167:00AMPRNUSMylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector
Mylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector Mylan doubling the eligibility for patient assistance, effectively eliminating out-of-pocket expense for uninsured and under-insured patients Company to cover up to $300 of out-of-pocket cost at pharmacy; reducing... More...>>
08/25/20166:30AMPRNUSMylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines...
Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency PR Newswire BENGALURU, India and HERTFORDSHIRE, England and PITTSBURGH, Aug. 25, 2016 BENGALURU, India and HERTFORDSHIRE, England and PITTSBURGH, Aug. 25, 2016 /PRNewswire/ -- Mylan N.V... More...>>
08/24/20166:20PMDJNMylan Faces Scrutiny Over EpiPen Price Increases
Mylan NV became the latest pharmaceutical company to face popular outrage about higher drug costs, as attacks mounted Wednesday on the company's substantial price increases for the EpiPen emergency allergy treatment. EpiPen is a lifesaving treatment for millions whose allergies can send them into severe shock, including... More...>>
08/24/20164:47PMPRNUSMylan Invalidates Two of Teva's Copaxone® 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Procee...
Mylan Invalidates Two of Teva's Copaxone® 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 24, 2016 HERTFORDSHIRE, England and PITTSBURGH, Aug. 24, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the... More...>>
08/11/20169:00AMPRNCABreathing Easier: Pharma Successfully Leveraging Smoother EU Regulatory Specs
Breathing Easier: Pharma Successfully Leveraging Smoother EU Regulatory Specs Canada NewsWire BOSTON, MA, Aug. 11, 2016 Pharma developer Pulmatrix, Inc. [NASDAQ:PULM], partnership with industry giant Mylan [NASDAQ:MYL] BOSTON, MA, Aug. 11, 2016 /CNW/ - [NASDAQ:PULM]: It's been less than two months since the Brexit... More...>>
08/11/20169:00AMPRNUSBreathing Easier: Pharma Successfully Leveraging Smoother EU Regulatory Specs
Breathing Easier: Pharma Successfully Leveraging Smoother EU Regulatory Specs PR Newswire BOSTON, MA, Aug. 11, 2016 Pharma developer Pulmatrix, Inc. [NASDAQ:PULM], partnership with industry giant Mylan [NASDAQ:MYL] BOSTON, MA, Aug. 11, 2016 /PRNewswire/ - [NASDAQ:PULM]: It's been less than two months since the Brexit... More...>>
08/10/20169:00AMDJNPerrigo Misses Expectations and Cuts Guidance
Drugmaker Perrigo Co. on Wednesday said it missed earnings expectations for the latest quarter and cut its guidance for the year as it continues to battle pricing pressure and competition in the market. Perrigo stock, which has lost more than half its value over the past 12 months, dropped 12% premarket to $83.39. "Our... More...>>
08/09/20166:10PMDJNMylan Backs Year View After Sales Rise 8%
Mylan NV logged 8% second-quarter sales growth, driven by a jump in specialty drug sales and higher sales of generic treatments. The pharmaceutical giant last month won regulatory clearance for its $7.2 billion acquisition of Swedish rival Meda. The deal comes about a year after Mylan fended off Israeli generic drugmaker... More...>>
08/09/20164:02PMPRNUSMylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8%
Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 9, 2016 HERTFORDSHIRE, England and PITTSBURGH, Aug. 9, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter and six months ended... More...>>
08/05/20169:25AMPRNUSMylan Completes Acquisition of Meda
Mylan Completes Acquisition of Meda PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 5, 2016 HERTFORDSHIRE, England and PITTSBURGH, Aug. 5, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it has completed the settlement of its recommended public offer to the shareholders of Meda Aktiebolag... More...>>
08/05/20169:14AMPRNUSMylan Completes Acquisition of Meda
Mylan Completes Acquisition of Meda PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 5, 2016 HERTFORDSHIRE, England and PITTSBURGH, Aug. 5, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it has completed the settlement of its recommended public offer to the shareholders of Meda Aktiebolag... More...>>
08/02/20168:42AMPRNUSMeda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 2, 2016 Mylan Has Declared the Offer Unconditional, with Settlement Expected to Occur on Aug. 5, 2016 Mylan Acts to Have Meda Shares Delisted from Nasdaq Stockholm HERTFORDSHIRE, England... More...>>
08/02/20168:40AMPRNUSMeda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer Mylan Has Declared the Offer Unconditional, with Settlement Expected to Occur on Aug. 5, 2016 Mylan Acts to Have Meda Shares Delisted from Nasdaq Stockholm PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 2, 2016 HERTFORDSHIRE, England... More...>>
08/01/20167:30AMPRNUSMylan Launches Generic Dexedrine® Capsules
Mylan Launches Generic Dexedrine® Capsules PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 1, 2016 HERTFORDSHIRE, England and PITTSBURGH, Aug. 1, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Dextroamphetamine Sulfate Extended-release Capsules, 5 mg, 10 mg, and 15 mg... More...>>
08/01/20167:00AMPRNUSMylan Launches Generic Propecia® Tablets
Mylan Launches Generic Propecia® Tablets PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 1, 2016 HERTFORDSHIRE, England and PITTSBURGH, Aug. 1, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Finasteride Tablets USP, 1 mg, a generic version of Merck's Propecia®. Mylan received... More...>>
07/28/20169:42AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Thursday's session are Raytheon Co. (RTN), Thermo Fisher Scienti-fic Inc. (TMO) and Alexion Pharmaceuticals Inc. (ALXN). Raytheon on Thursday raised its full-year profit guidance, completing a clean sweep of improved outlooks among the largest U.S. military... More...>>
07/27/20165:19PMPRNUSMylan Receives U.S. FTC Clearance for Proposed Meda Acquisition
Mylan Receives U.S. FTC Clearance for Proposed Meda Acquisition PR Newswire HERTFORDSHIRE, England and PITTSBURGH, July 27, 2016 Mylan Has Now Received All Antitrust Regulatory Clearances to Acquire Meda HERTFORDSHIRE, England and PITTSBURGH, July 27, 2016 /PRNewswire/ -- The Offer is not being made, and this press release... More...>>
07/27/20165:19PMPRNUSMylan Receives U.S. FTC Clearance for Proposed Meda Acquisition
Mylan Receives U.S. FTC Clearance for Proposed Meda Acquisition Mylan Has Now Received All Antitrust Regulatory Clearances to Acquire Meda PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, July 27, 2016 HERTFORDSHIRE, England, and PITTSBURGH, July 27, 2016 /PRNewswire/ -- The Offer is not being made, and this press... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20160826 03:19:21